NCT01465568View on ClinicalTrials.gov

Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

June 30, 2014

Conditions
Osteoporosis
Interventions
DRUG

Denosumab

60mg subcutaneous injection 6 monthly for 2 doses

DRUG

bisphosphonates

continue present bisphosphonate treatment

Trial Locations (1)

Unknown

Tuen Mun Hospital, Hong Kong

All Listed Sponsors
lead

Tuen Mun Hospital

OTHER_GOV

NCT01465568 - Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis | Biotech Hunter | Biotech Hunter